Dermatol. praxi. 2010;4(4):202-204

The results of the clinical study of Acneon (lactoferrin) in patients with acne vulgaris

doc.MUDr.Jarmila Rulcová, CSc.1, Mgr.Jan Heinrich2, Ing.Irena Palíková, Ph.D.3
1 Dermatovenerologická klinika LF MU a FN Brno-Bohunice
2 Walmark, a. s., Třinec
3 Ústav lékařské chemie a biochemie, LF UP Olomouc

In this work we summarize the results of lactoferrin (included in Acneon tablets preparate, Walmark) administration in patients suffering

from acne papulopustulosa (grade I–IV). We evaluate an effect on both non-inflammatory and inflammatory acne lesions, on tolerance

of a preparation and on satisfaction of patients. The outcome of two month surveillance was statistically significant reduction in number

of both comedones and papulopustules.

Keywords: acne vulgaris, lactoferrine, Acneon

Published: December 10, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rulcová J, Heinrich J, Palíková I. The results of the clinical study of Acneon (lactoferrin) in patients with acne vulgaris. Dermatol. praxi. 2010;4(4):202-204.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aktan S, Ozmen E, Berna S. Anxiety, depression, and nature of acne vulgaris in adolescents. Int. J. Derm., 2000; 39(5): 354-357. Go to original source... Go to PubMed...
    2. Acne Percentage: AHRQ Evidence Reports, Management of Acne Volume 1, 2001.
    3. TRU projects teens will spend $169 billion in 2004. www. teenresearch.com., 2004, december.
    4. Caccavo DN, Pellegrino M, Altamura A, et al. Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. J Endotoxin Res, 2000; 8: 403-417. Go to original source...
    5. Valenti P, Berlutti F, Conte MP, Longhi C, Seganti L. Lactoferrin functions: current status and perspectives. J Clin Gastroenterol, 2004; 38: 127-129. Go to original source... Go to PubMed...
    6. Yamaguchi H, Abe S, Takakura N. Potential usefulness of bovine lactoferrin for adjunctive immunotherapy for mucosal Candida infections. Biometals, 2004; 17: 245-248. Go to original source... Go to PubMed...
    7. Farnaud S, Evans RW. Lactoferrin a multifunctional protein with antimicrobial properties. Mol Immunol, 2003; 40: 395-405. Go to original source... Go to PubMed...
    8. Teraguchi S, Wakabayashi H, Kuwata H, et al. Protection against infections by oral lactoferrin: evaluation in animal models. Biometals, 2004; 17: 231-234. Go to original source... Go to PubMed...
    9. Ward PP, Conneely OM. Lactoferrin: role in iron homeostasis and host defense against microbial infection. Biometals, 2004; 17: 203-208. Go to original source... Go to PubMed...
    10. Brock J. Lactoferrin: a multifunctional immunoregulatory protein? Immunol Today 1995; 16: 417-419. Go to original source... Go to PubMed...
    11. Cumberbatch M, Bhushan M, Dearman RJ, et al. IL-1betainduced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol, 2003; 132: 352-359. Go to original source... Go to PubMed...
    12. Kimber I, Cumberbatch M, Dearman RJ, et al. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol, 2002; 80: 103-107. Go to original source... Go to PubMed...
    13. Chiba K, Yoshizawa K, Makino I, et al. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci, 2000; 25: 77-83. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.